Cargando…
A Metabolomic and Transcriptomic Study Revealed the Mechanisms of Lumefantrine Inhibition of Toxoplasma gondii
Toxoplasma gondii is an obligate protozoon that can infect all warm-blooded animals including humans. T. gondii afflicts one-third of the human population and is a detriment to the health of livestock and wildlife. Thus far, traditional drugs such as pyrimethamine and sulfadiazine used to treat T. g...
Autores principales: | Li, Meiqi, Sang, Xiaoyu, Zhang, Xiaohan, Li, Xiang, Feng, Ying, Yang, Na, Jiang, Tiantian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10003460/ https://www.ncbi.nlm.nih.gov/pubmed/36902335 http://dx.doi.org/10.3390/ijms24054902 |
Ejemplares similares
-
Determination of lumefantrine as an effective drug against Toxoplasma gondii infection – in vitro and in vivo study
por: Wang, Dawei, et al.
Publicado: (2021) -
Transcriptomic and metabolomic analyses reveal the essential nature of Rab1B in Toxoplasma gondii
por: He, Kai, et al.
Publicado: (2023) -
The transcriptome of Toxoplasma gondii
por: Radke, Jay R, et al.
Publicado: (2005) -
Co-Immunization with DNA Vaccines Expressing SABP1 and SAG1 Proteins Effectively Enhanced Mice Resistance to Toxoplasma gondii Acute Infection
por: Sang, Xiaoyu, et al.
Publicado: (2023) -
Global Transcriptome Profiling of Multiple Porcine Organs Reveals Toxoplasma gondii-Induced Transcriptional Landscapes
por: He, Jun-Jun, et al.
Publicado: (2019)